Comments to FDA: Antiplaque, Antigingivitis Share page: Docket Number: 81N-033P Comments regarding "Oral Health Care Drug Products for Over-the-Counter Human Use; Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph". Download Document Issues: OTC Medicines Related Posts Press Releases and Statements CHPA Responds to Section 232 Investigation on Pharmaceuticals Apr 15, 2025 Press Releases and Statements CHPA Commends Lawmakers for Urging FDA to Protect the Rx-OTC-Switch Pathway Apr 11, 2025 Press Releases and Statements House Leaders Prioritize OMUFA Renewal, CHPA Welcomes Progress Apr 1, 2025